TAK1-inhibitors did not reduce disease burden in a V&#954;*MYC model of multiple myeloma.

Håland, Erling; Moen, Ingrid Nyhus; Vandsemb, Esten N; Starheim, Kristian K

TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.

Håland, Erling; Moen, Ingrid Nyhus; Vandsemb, Esten N; Starheim, Kristian K.

Afiliação

Håland E; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.
Moen IN; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.
Vandsemb EN; CEMIR Centre of Molecular Inflammation Research, IKOM, NTNU, Trondheim, Norway.
Starheim KK; Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.

BMC Res Notes ; 15(1): 352, 2022 Nov 26.

Article em En | MEDLINE | ID: mdl-36435864

Assuntos

Mieloma Múltiplo; Zearalenona; Camundongos; Animais; Mieloma Múltiplo/tratamento farmacológico; Zearalenona/farmacologia; Efeitos Psicossociais da Doença

Palavras-chave

5Z-7; Haematological malignancy; Multiple myeloma; NG25; TAK1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Zearalenona / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google